PRO recommendation

Mark W. Elliott (Leeds (West Yorkshire), United Kingdom)

Source: ERS Course 2018 - Noninvasive ventilation: advanced
Number: 10
Disease area: Respiratory critical care

Slide presentationWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mark W. Elliott (Leeds (West Yorkshire), United Kingdom). PRO recommendation. ERS Course 2018 - Noninvasive ventilation: advanced

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PRO: maintenance is cost-effective
Source: Annual Congress 2012 - Pro/Con Debate "Cost-effectiveness of maintenance chemotherapy for NSCLC"
Year: 2012


From kitchen table questionnaires to valid PRO: how PRO's can provide insight in clinical events, the EXACT-PRO example
Source: Annual Congress 2012 - An ERS/ELF joint session "New tools to assess improvement in respiratory patients: capturing the patient's perspective"
Year: 2012


Use of antifibrotics in post-COVID ILD: PRO
Source: Virtual Congress 2021 – Post COVID interstitial lung diseases syndrome: diagnosis and management as interstitial lung disease?
Year: 2021


PRO - Steroids in ARDS
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


PRO: Severity scores are useful
Source: Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Year: 2012


NIV and pneumonia - PRO & CON
Source: ERS course 2015
Year: 2015

Is there a place for oral mucolytics in the prevention of LRTI? - PRO
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009



PRO - Lung biopsy in ARDS
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


Analysis of the patient-reported outcome (PRO) endpoints found in labeling claims of asthma drugs in Europe
Source: Eur Respir J 2007; 30: Suppl. 51, 193s
Year: 2007

Long term application of NIV in COPD - PRO & CON
Source: ERS course 2015
Year: 2015


Debate: Antibiotic treatment is contraindicated in acute bronchitis - PRO
Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Year: 2008


How do regulatory authorities feel about "PRO"?
Source: Annual Congress 2012 - An ERS/ELF joint session "New tools to assess improvement in respiratory patients: capturing the patient's perspective"
Year: 2012


Prediction of the lung dose in young children by cascade impaction methods alternatively to the SAINT model
Source: Eur Respir J 2004; 24: Suppl. 48, 621s
Year: 2004

Pro-con debate: Does it make sense to view rapidly progressive ILD as a distinct clinical entity? - PRO
Source: Virtual Congress 2020 – When the lung gets stiff
Year: 2020